Health

Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody

SUZHOU and HANGZHOU, China, Jan. 20, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D and manufacturing of antibody-based therapeutics, announces today that an investigational new drug (IND) appl...

2020-01-21 00:00 385

TenNor Therapeutics Received FDA Orphan Drug Designation

SUZHOU, China, Jan. 20, 2020 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designation for TNP-2092 to treat prosthetic joint infections. Medical devices such as prosthetic joints, central venous catheters and artificial hear...

2020-01-20 20:50 352

Venus Medtech Announces the Addition of Two Cardiovascular Experts to Their Advisory Team

HANGZHOU, China, Jan. 20, 2020 /PRNewswire/ -- The leading transcatheter heart valve medical device player inChina - Venus Medtech (Hangzhou) Inc. ("Venus Medtech" or the "Company", stock code: 2500.HK), today is pleased to announce the appointment of two new cardiovascular experts to its advisor...

2020-01-20 18:04 6823

Mindray Launches New TE7 ACE Point-of-Care Solution to Improve Diagnostic Confidence

SHENZHEN, China, Jan. 20, 2020 /PRNewswire/ -- Mindray Medical (SZSE: 300760), a leading global provider of medical devices and solutions, announces the release of its new Point-of-Care Ultrasound System,TE7 ACE . This new Touch Screen Ultrasound ...

2020-01-20 16:00 366

Milk without the cow: TurtleTree Labs, world's first company producing milk from cells, secures pre-seed funding

* The pre-seed round was led by Lever VC with K2 Global and KBW Ventures backing TurtleTree Labs * TurtleTree is the world's first company using technology to create real milk from animal cells, with no animal needed. * The raise will be used to onboard more scientists to the TurtleTree team...

2020-01-20 15:37 320

KT and Samsung Medical Center to Build 5G Smart Hospital

* World's First Application of 5G Technology in Medical Practice * Sync Cams Share Real-Time HD Video Footage of Surgery for Teaching * 5G Network Base Made Secure for Medical Service Development * Enterprise-Dedicated 5G Network Protects Private Medical Info from Hacking SEOUL, South Korea...

2020-01-20 13:47 6878

China-Based Ivy Capital Invests in Betagenon's Clinical Stage AMPK Activator Program

STOCKHOLM, Jan. 20, 2020 /PRNewswire/ -- Balticgruppen Bio, the Umea based Biotech company focused on development of AMPK activator compounds, operating under the trademark Betagenon, has closed a funding round withChina based asset management firm Ivy Capital granting the company 3 MUSD of fundi...

2020-01-20 11:14 348

Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC

SEONGNAM, South Korea, Jan. 19, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration (FDA) has been cleared ...

2020-01-20 10:44 288

QBiotics receives first registration for tigilanol tiglate with European Medicines Agency approval of Stelfonta(R)

* STELFONTA® (tigilanol tiglate) approved by the European Medicines Agency (EMA), making it the first pharmaceutical treatment available for all grades of canine non-metastatic mast cell tumours (MCT)[1] * The approval marks the first registration of QBiotic's, lead compound tigilanol tiglate...

2020-01-20 07:00 614

111 Unveils New Video on The Impact of Chinese Policies to Medical Industry

SHANGHAI, Jan. 19, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the sixth episode in its 111 Insight series. The title announced today,The Impact of Chinese Policies to Medical Industry,...

2020-01-19 18:00 7323

Happiness Biotech Group Limited Announces Financial Results for the Six Months Ended September 30, 2019

NANPING, China, Jan. 17, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months endedSeptember 30, 2019. The financial results...

2020-01-17 21:00 9119

111, Inc. Featured at 38th Annual JP Morgan Healthcare Conference

SHANGHAI, Jan. 17, 2020 /PRNewswire/ -- Junling Liu, co-founder, Chairman, and Chief Executive Officer of 111, Inc. (NASDAQ: YI) a leading integrated online and offline healthcare platform, gave an address entitled "Driving Transformation inChina's Healthcare and Pharmaceutical Industry" at the 3...

2020-01-17 20:00 6537

Snap Fitness Poised for Continued International Expansion in 2020

Fitness brand builds upon strong growth in 2019, with 50+ New Locations Opened CHANHASSEN, Minnesota, Jan. 16, 2020 /PRNewswire/ -- New clubs, new territories and new milestones are on the horizon for Snap Fitness. With more than one million members and 2,000+ clubs open or scheduled for developm...

2020-01-16 22:15 531

China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory

TAIZHOU, China, Jan. 16, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Ad...

2020-01-16 21:00 5138

LimaCorporate Inaugurates the New Research & Innovation Center for 3D Printing and the Advanced Laboratory for Testing and Analysis (ATLAs)

UDINE, Italy, Jan. 16, 2020 /PRNewswire/ -- LimaCorporate announces the official opening of new spaces entirely dedicated to 3D Printing and advanced testing: the Research & Innovation Center (R&I Center) and the Advanced Laboratory for Testing and Analysis (ATLAs). These new areas are located in...

2020-01-16 21:00 592

Transamerica Life Bermuda's Excellent Customer Service Recognised at the Benchmark Wealth Management Awards

HONG KONG, Jan. 16, 2020 /PRNewswire/ -- Transamerica Life (Bermuda) Ltd. (TLB), a leading High Net Worth (HNW) life insurer, has won the "Outstanding Achiever" award at the 10th Benchmark Wealth Management Awards in Hong Kong in the category for "High Net Worth Client Servicing".   

2020-01-16 16:21 662

"Every Person Deserves the Chance to Live a Healthy and Productive Life" -- 2020 BUTTON Healthcare Cross-Border Partnering Summit -- From Globe to Asia

HEFEI, China, Jan. 16, 2020 /PRNewswire/ -- On the morning of January 13, 2020 (Pacific Time), the 38th J.P. Morgan Healthcare Conference opened in San Francisco as scheduled. At the same time, the "BUTTON Healthcare Cross-Border Partnering Summit - From Globe toAsia" was grandly held at the Merc...

2020-01-16 16:11 362

WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany

* First drug product facility in Europe to complement WuXi Biologics' existing commercial manufacturing capacities * WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer SHANGHAI and LEVERKUSEN, Germany, Jan. 15, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2020-01-16 10:39 10177

FDF China to be held in June to boost Chinese pharmaceutical enterprises to "go global" and promote the innovation and development of industry

SHANGHAI, Jan. 16, 2020 /PRNewswire/ -- FDF China, collocated with CPhI China, will be held fromJune 22-24, 2020 at Shanghai New International Expo Centre (SNIEC). More and more formulation enterprises need to implement strategic layout to step up cooperation in innovation and facilitate the inte...

2020-01-16 09:52 456

Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline"

SEOUL, South Korea, Jan. 15, 2020 /PRNewswire/ -- The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Morgan Healthcare Conference inSan Francisco during Jan. 13-15, which it presented its vision and major R&D strategies for 2020. ...

2020-01-16 07:30 356
123456 ... 791